✦ LIBER ✦

Randomised placebo-controlled trial of use of topical recombinant bovine basic fibroblast growth factor for second-degree burns

✍ Scribed by Xiaobing Fu; Zuyao Shen; Yulin Chen; Junhe Xie; Zhenrong Guo; Mingliang Zhang; Zhiyong Sheng

Book ID: 117311183
Publisher: The Lancet
Year: 1998
Tongue: English
Weight: 116 KB
Volume: 352
Category: Article
ISSN: 0140-6736
DOI: 10.1016/s0140-6736(98)01260-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Randomized, multicenter, double-blind, a

Randomized, multicenter, double-blind, and placebo-controlled trial using topical recombinant human acidic fibroblast growth factor for deep partial-thickness burns and skin graft donor site

✍ Ma Bing; Cheng Da-Sheng; Xia Zhao-Fan; Ben Dao-Feng; Lu Wei; Cao Zhi-Fang; Wang 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 158 KB

A local application of recombinant human

A local application of recombinant human fibroblast growth factor 2 for tibial shaft fractures: A randomized, placebo-controlled trial

✍ Hiroshi Kawaguchi; Hiroyuki Oka; Seiya Jingushi; Toshihiro Izumi; Masao Fukunaga 📂 Article 📅 2010 🏛 American Society for Bone and Mineral Research 🌐 English ⚖ 893 KB

## Abstract Fibroblast growth factor 2 (FGF‐2) is a potent mitogen for mesenchymal cells, and a local application of recombinant human FGF‐2 (rhFGF‐2) in a gelatin hydrogel has been reported to accelerate bone union in our animal studies and preparatory dose‐escalation trial on patients with surgic